Skip to main content

58 - References

References

386 The Maudsley® Prescribing Guidelines in Psychiatry CHAPTER 3 References

  1. Pluijms EM, et al. Influence of an adjuvant antidepressant on the efficacy of electroconvulsive therapy: a systematic review and meta-­analysis. Aust N Z J Psychiatry 2021; 55:366–380.
  2. Janjua AU, et al. The efficacy and safety of concomitant psychotropic medication and electroconvulsive therapy (ECT). CNS Drugs 2020; 34:509–520.
  3. Bundy BD, et al. Influence of anesthetic drugs. and concurrent psychiatric medication on seizure adequacy during electroconvulsive therapy. J Clin Psychiatry 2010; 71:775–777.
  4. Singh PM, et al. Evaluation of etomidate for seizure duration in electroconvulsive therapy: a systematic review and meta-­analysis. J ECT 2015; 31:213–225.
  5. Ren L, et al. Comparative efficacy and tolerability of different anesthetics in electroconvulsive therapy for major depressive disorder: a systematic review and network meta-­analysis. J Psychiatr Res 2024; 171:116–125.
  6. Stripp TK, et al. Anaesthesia for electroconvulsive therapy – new tricks for old drugs: a systematic review. Acta Neuropsychiatr 2018; 30:61–69.
  7. Ren L, et al. Clinical efficacy of adjunctive esketamine anesthesia in electroconvulsive therapy for major depressive disorders: a pragmatic, randomized, controlled trial. Psychiatry Res 2024; 335:115843.
  8. Zeng QB, et al. Efficacy and safety of esketamine versus propofol in electroconvulsive therapy for treatment-­resistant depression: a randomized, double-­blind, controlled, non-­inferiority trial. J Affect Disord 2024; 368:320–328.
  9. McGirr A, et al. Adjunctive ketamine in electroconvulsive therapy: updated systematic review and meta-­analysis. Br J Psychiatry 2017; 210:403–407.
  10. Zheng W, et al. Adjunctive ketamine and electroconvulsive therapy for major depressive disorder: a meta-­analysis of randomized controlled trials. J Affect Disord 2019; 250:123–131.
  11. van Waarde JA, et al. Clinical predictors of seizure threshold in electroconvulsive therapy: a prospective study. Eur Arch Psychiatry Clin Neurosci 2013; 263:167–175.
  12. Nyhuis P, et al. Augmentation of electroconvulsive therapy with oral caffeine: a retrospective analysis of 40 patients with major depression. Pharmacopsychiatry 2024; 57:30–34.
  13. Gistelinck L, et al. Effectiveness and safety of flumazenil augmentation during electroconvulsive therapy. J ECT 2024; 40:e49–e51.
  14. Sterina E, et al. Acute and prophylactic management of postictal agitation in electroconvulsive therapy. J ECT 2023; 39:136–140.
  15. Feenstra TC, et al. Pharmacological prevention of postictal agitation after electroconvulsive therapy-­a systematic review and meta-­analysis. Front Psychiatry 2023; 14:1170931.
  16. Calderon K, et al. Serotonin toxicity associated with electroconvulsive therapy: a case report. J Acad Consult Liaison Psychiatry 2024; S2667-­2960(24)00084-­3. doi: 10.1016/j.jaclp.2024.08.002.
  17. Cheng YC, et al. Serotonin syndrome after electroconvulsive therapy in a patient on trazodone, bupropion, and quetiapine: a case report. Clin Neuropharmacol 2015; 38:112–113.
  18. Deuschle M, et al. Electroconvulsive therapy induces transient sensitivity for a serotonin syndrome: a case report. Pharmacopsychiatry 2017; 50:41–42.
  19. Linton CR, et al. Using thiamine to reduce post-­ECT confusion. Int J Geriatr Psychiatry 2002; 17:189–192.
  20. Verdijk J, et al. Pharmacological interventions to diminish cognitive side effects of electroconvulsive therapy: a systematic review and meta-­ analysis. Acta Psychiatr Scand 2022; 145:343–356.
  21. Isuru A, et al. A randomized, double-­blind, placebo-­controlled trial on the role of preemptive analgesia with acetaminophen [paracetamol] in reducing headache following electroconvulsive therapy [ECT]. BMC Psychiatry 2017; 17:275.
  22. Leung M, et al. Pretreatment with ibuprofen to prevent electroconvulsive therapy-­induced headache. J Clin Psychiatry 2003; 64:551–553.
  23. Markowitz JS, et al. Intranasal sumatriptan in post-­ECT headache: results of an open-­label trial. J ECT 2001; 17:280–283.
  24. Royal College of Psychiatrists. The ECT Handbook, 4th edn. London: RCPsych Publications; 2019.
  25. Kellner CH, et al. ECT–drug interactions: a review. Psychopharmacol Bull 1991; 27:595–609.
  26. Naguib M, et al. Interactions between psychotropics, anaesthetics and electroconvulsive therapy: implications for drug choice and patient management. CNS Drugs 2002; 16:229–247.
  27. Maidment I. The interaction between psychiatric medicines and ECT. Hosp Pharm 1997; 4:102–105.
  28. Havaki-­Kontaxaki BJ, et al. Concurrent administration of clozapine and electroconvulsive therapy in clozapine-­resistant schizophrenia. Clin Neuropharmacol 2006; 29:52–56.
  29. Nothdurfter C, et al. The influence of concomitant neuroleptic medication on safety, tolerability and clinical effectiveness of electroconvulsive therapy. World J Biol Psychiatry 2006; 7:162–170.
  30. Gazdag G, et al. The impact of neuroleptic medication on seizure threshold and duration in electroconvulsive therapy. Ideggyogy Sz 2004; 57:385–390.
  31. Oulis P, et al. Corrected QT interval changes during electroconvulsive therapy-­antidepressants-­atypical antipsychotics coadministration: safety issues. J ECT 2011; 27:e4–e6.
  32. Grover S, et al. Combined use of clozapine and ECT: a review. Acta Neuropsychiatr 2015; 27:131–142.
  33. Flamarique I, et al. Electroconvulsive therapy and clozapine in adolescents with schizophrenia spectrum disorders: is it a safe and effective combination? J Clin Psychopharmacol 2012; 32:756–766.
  34. van Waarde JA, et al. Patient, treatment, and anatomical predictors of outcome in electroconvulsive therapy: a prospective study. J ECT 2013; 29:113–121.
  35. Sienaert P, et al. Concurrent use of lamotrigine and electroconvulsive therapy. J ECT 2011; 27:148–152.

Depression and anxiety disorders CHAPTER 3 36. Jahangard L, et al. Comparing efficacy of ECT with and without concurrent sodium valproate therapy in manic patients. J ECT 2012; 28:118–123. 37. Gillving C, et al. Seizure duration and electroconvulsive therapy in major depressive disorder. JAMA Netw Open 2024; 7:e2422738. 38. Tang VM, et al. Should benzodiazepines and anticonvulsants be used during electroconvulsive therapy? A case study and literature review. J ECT 2017; 237–242. 39. Chiao S, et al. Psychotropic medication effects on seizure threshold and seizure duration during electroconvulsive therapy stimulus titration. J ECT 2020; 36:115–122. 40. Hanretta AT, et al. Combined use of ECT with duloxetine and olanzapine: a case report. J ECT 2006; 22:139–141. 41. Heinz B, et al. Postictal ventricular tachycardia after electroconvulsive therapy treatment associated with a lithium–duloxetine combination. J ECT 2013; 29:e33–e35. 42. Jha AK, et  al. Negative interaction between lithium and electroconvulsive therapy: a case-­control study. Br J Psychiatry 1996; 168:241–243. 43. Rucker J, et al. A case of prolonged seizure after ECT in a patient treated with clomipramine, lithium, L-­tryptophan, quetiapine, and thyroxine for major depression. J ECT 2008; 24:272–274. 44. Galvez V, et al. Predictors of seizure threshold in right unilateral ultrabrief electroconvulsive therapy: role of concomitant medications and anaesthesia used. Brain Stimul 2015; 8:486–492. 45. Dolenc TJ, et al. Electroconvulsive therapy in patients taking monoamine oxidase inhibitors. J ECT 2004; 20:258–261. 46. Horn PJ, et al. Transdermal selegiline in patients receiving electroconvulsive therapy. Psychosomatics 2010; 51:176–178. 47. Li TC, et al. Mirtazapine relieves post-­electroconvulsive therapy headaches and nausea: a case series and review of the literature. J ECT 2011; 27:165–167. 48. Masdrakis VG, et al. The safety of the electroconvulsive therapy-­escitalopram combination. J ECT 2008; 24:289–291. 49. Okamoto N, et al. Transient serotonin syndrome by concurrent use of electroconvulsive therapy and selective serotonin reuptake inhibitor: a case report and review of the literature. Case Rep Psychiatry 2012; 2012:215214. 50. Klysner R, et al. Transient serotonin toxicity evoked by combination of electroconvulsive therapy and fluoxetine. Case Rep Psychiatry 2014; 2014:162502. 51. Birkenhager TK, et  al. Possible synergy between electroconvulsive therapy and imipramine: a case report. J Psychiatr Pract 2016; 22:478–480. 52. Gonzalez-­Pinto A, et al. Efficacy and safety of venlafaxine–ECT combination in treatment-­resistant depression. J Neuropsychiatry Clin Neurosci 2002; 14:206–209.

No comments to display

Back to top